Oura Ring IPO Targets $2.2 Billion Valuation

Smart ring pioneer Oura has officially filed for its initial public offering on the Nasdaq, aiming to raise up to $2.2 billion. The Finnish-American firm and its existing shareholders are offering a combined 50 million shares, with pricing anticipated between $40 and $44 per share. At the upper end of this range, Oura would command a market capitalization of approximately $14.1 billion, marking a significant valuation milestone for the wearable technology company.

The IPO structure reveals a substantial portion of the offering, nearly two-thirds or 36.5 million shares, originates from current investors looking to realize gains. Leading this divestment is venture capital firm Forerunner Ventures, which plans to exit its entire 9.3% stake, representing roughly 28.7 million shares. This move alone accounts for almost 80% of the shares being sold by existing backers, potentially netting Forerunner Ventures around $1.20 billion before fees and taxes at the midpoint valuation. Other significant investors like Eli Lilly and funds associated with Dragoneer have indicated interest in purchasing up to $100 million and $300 million in shares, respectively. Notably, Eli Lilly also holds a $50 million SAFE note set to convert into equity during the IPO.

While the IPO provides a liquidity event for early backers, Oura itself is set to receive a smaller portion of the proceeds, estimated at around $567 million at the top of the range. A significant portion of these funds, approximately $526.4 million, is earmarked to cover tax liabilities arising from the vesting of employee restricted stock units triggered by the listing. This strategic allocation means the company's existing cash reserves of $371.8 million remain largely untouched, avoiding the need for additional debt financing.

Oura's financial performance leading up to the IPO demonstrates robust growth, particularly in its subscription services. For the first nine months of its fiscal year, the company reported revenue of $1.214 billion, a 74% increase year-over-year. Net income saw a substantial jump from $1.6 million to $60.8 million. While hardware sales, totaling $974 million, still form the majority of revenue, the subscription segment is rapidly expanding, contributing $240.5 million or approximately 20% of total revenue. This recurring revenue stream boasts a high gross margin of 89%, significantly boosting Oura's overall gross margin to 55%.

The company projects ending the fiscal year with close to 5.7 million paying members, nearly doubling its subscriber base from the previous year. This growth is fueled by a high conversion rate, with over 94% of activated rings transitioning to paid memberships. Oura's data advantage, built on nearly 42 billion hours of longitudinal biometric data and over 1,140 patents, positions it as a key player in the healthtech sector. Competitors in this space include giants like Apple, Google (Fitbit), and Samsung, as well as specialized firms such as Coros, Garmin, and Whoop.

The proposed valuation reflects a dramatic increase in Oura's market standing. Less than a year ago, the company was valued at approximately $11 billion following a $900 million funding round. Prior to that, a $200 million investment round valued the company at $5.2 billion. This trajectory underscores the increasing investor appetite for companies leveraging data analytics and subscription models within the rapidly expanding wearable technology and digital health markets, a sector projected for continued expansion driven by consumer demand for personalized health insights.